Skip to main content

Table 4 Analysis of NLR in general population

From: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma

Group

NLR

ESCC patients

3.23

238 cases

1.66

818 cases

 

All

1.61

Age

   < 60

1.64

  ≥ 60

1.51

Sex

 Male

1.64

 Female

1.58

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us